Search results
Does Atara Biotherapeutics (ATRA) Have the Potential to Rally 204% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 2 years agoThe mean of analysts' price targets for Atara Biotherapeutics (ATRA) points to a 204.1% upside in...
The past five years for Atara Biotherapeutics (NASDAQ:ATRA) investors has not been profitable
Simply Wall St. via Yahoo Finance· 1 year agoAtara Biotherapeutics, Inc. (NASDAQ:ATRA) shareholders should be happy to see the share price up 19%...
Time To Worry? Analysts Just Downgraded Their Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Outlook
Simply Wall St. via Yahoo Finance· 11 months agoThe latest analyst coverage could presage a bad day for Atara Biotherapeutics, Inc. (NASDAQ:ATRA),...
Atara Biotherapeutics (NASDAQ:ATRA) shareholders are up 17% this past week, but still in the red...
Simply Wall St. via Yahoo Finance· 2 years agoThis week we saw the Atara Biotherapeutics, Inc. (NASDAQ:ATRA) share price climb by 17%. But only...
After losing 76% in the past year, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) institutional owners...
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Institutions' substantial holdings in Atara Biotherapeutics implies that they have...
Atara (ATRA) Up 11% on Regulatory Update From Blood Cancer Study
Zacks via Yahoo Finance· 8 months agoAtara (ATRA) rises 11% on an update regarding the regulatory pathway for the company's lead product...
Atara Biotherapeutics (ATRA) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoAtara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -5.13% and 2.13%,...
Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding
GuruFocus.com via Yahoo Finance· 4 months agoOverview of Seth Klarman (Trades, Portfolio)'s Recent Stock Transaction Renowned value investor Seth...
3 Stocks to Buy That Could Be the Next Biotech Breakthrough
InvestorPlace via Yahoo Finance· 1 year agoIn general, biotech stocks are not ideal for conservative investors. The companies in search of the...
Atara Biotherapeutics (ATRA) Slumps 57% in a Month: Here's Why
Zacks via Yahoo Finance· 6 months agoAtara Biotherapeutics ATRA is a biotech company focused on developing off-the-shelf cell therapies...